drugset / Trial / NCT01192295
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the safety of oxycodone hydrochloride (HCl) controlled-release (CR) tablets in opioid tolerant pediatric patients aged 6 to 16 years, inclusive, with moderate to severe malignant and/or nonmalignant pain requiring opioid therapy.
Timeline
- Start
- 2010-11
- Primary completion
- 2014-07
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxycodone | Other / unclassified | 10 mg | — |
| Subject | Oxycodone | Other / unclassified | 15 mg | — |
| Subject | Oxycodone | Other / unclassified | 20 mg | — |
| Subject | Oxycodone | Other / unclassified | 30 mg | — |
| Subject | Oxycodone | Other / unclassified | 40 mg | — |
Indications
No indication recorded.